Formation of hydrated nanocellulose sheets with or without a binder for the use as a dermatological treatment

Abstract

The present invention is a hydrated, nanocellulose nonwoven sheet and method for manufacturing the nanocellulose sheet having dermatologically active ingredients. The sheet is formed through a high pressure or vacuum filtration process from a dilute suspension. This suspension, which contains the nanocellulose, may also contain dermatologically active ingredients. The dermatologically active ingredients are incorporated into the unwoven sheet. The dilute suspension may contain binding agents that improve the strength of the nonwoven nanocellulose sheet. These binding agents can also be cross-linked after the formation of the sheet by applying other chemical agents or treating the sheet after formation.

Claims

1. A method of manufacture for forming a hydrated, nonwoven nanocellulose sheet, said method comprising the steps of: providing an amount of nanocellulose; forming a first suspension by diluting said amount of nanocellulose into a suspension medium; forming a binding agent solution by adding a binding agent to said first suspension to a mass concentration of 0.01 grams per liter to 10 grams per liter; forming a cross-linking solution by diluting a cross-linking agent in a solvent to a mass concentration of 0.001 grams per liter to 20 grams per liter to form a cross-linking solution; forming a gel by dispensing said binding agent solution into said cross-linking solution; collecting said gel from said cross-linking solution; forming a second suspension by re-dispersing said gel into a solvent; and forming the hydrated, nonwoven nanocellulose sheet by placing said second suspension into a dispensing device to filter said second suspension.

2. The method of manufacture of claim 1, further comprising the step of cutting said sheet into a predetermined shape and size.

3. The method of manufacture of claim 2, further comprising the step of packaging said sheet after the cutting step.

4. The method of manufacture of claim 1, further comprising the step of adding an amount of a dermatologically active ingredient to said first suspension after forming said first suspension.

5. The method of manufacture of claim 4, wherein said dermatologically active ingredient comprises an oil component and an alkyl-modified carboxyvinyl polymer component.

6. The method of manufacture of claim 4, wherein a diameter of said nanocellulose is 5 to 100 nm and a length of said nanocellulose is up to 10 microns.

7. The method of manufacture of claim 4, wherein said dermatologically active ingredient is selected from the group consisting of silver, collagen proteins, fragrances, and antioxidants.

8. The method of manufacture of claim 7, further comprising the step of cutting said sheet into a predetermined shape and size.

9. The method of manufacture of claim 8, further comprising the step of packaging said sheet after the cutting step.

10. The method of manufacture of claim 8, wherein said predetermined shape and size is a facial mask.

11. The method of manufacture of claim 7, wherein said dermatologically active ingredient comprises an oil component and an alkyl-modified carboxyvinyl polymer component.

Description

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

(1) FIG. 1 is a perspective view of a nanocellulose sheet manufactured by the present method.

(2) FIG. 2A is a perspective view of a nanocellulose sheet manufactured by the present method and formed into a mask.

(3) FIG. 2B is a perspective view of a nanocellulose sheet manufactured by the present method and formed into eye masks.

(4) FIG. 2C is a perspective view of a nanocellulose sheet manufactured by the present method and formed into side of face masks.

(5) FIG. 2D is a perspective view of a nanocellulose sheet manufactured by the present method and formed into a neck mask.

(6) FIG. 3 is a diagram of the steps of one embodiment of the present method of manufacture.

(7) FIG. 4 is a diagram of the steps of another embodiment of the present method of manufacture.

(8) FIG. 5 is a diagram of the steps of another embodiment of the present method of manufacture.

REFERENCE NUMERALS IN THE DRAWINGS

(9) 10 sheet 12 mask 13 eye mask 14 providing purified nanocellulose (step 1) 15 side of face mask 16 diluting nanocellulose into a suspension medium (step 2) 17 neck mask 18 placing first suspension into dispensing device 20 diluting a cross-linking agent in a solvent to form a cross-linking solution 22 dispensing first suspension into cross-linking solution 24 collecting a formed gel 26 re-dispersing formed gel in a solution to form a second suspension 28 filtering second suspension such that a sheet is formed 30 dipping formed sheet into a binding and/or cross-linking agent 32 dipping formed sheet into an ingredient slurry 34 cutting sheet into a form 36 packaging sheet 38 adding a binding agent to first suspension 40 adding an amount of ingredients to first suspension

DETAILED DESCRIPTION OF THE INVENTION

(10) The present invention provides a method for producing a hydrated, nanocellulose nonwoven sheet 10, as shown in FIG. 1. The present invention uses a novel process of manufacturing in order to create a nanocellulose nonwoven sheet. This sheet is formed by utilizing nanocellulose. Nanocellulose refers to nano-structured cellulose. In the present invention, this may be either cellulose nanofibers (also called microfibrillated cellulose) or nanocrystalline cellulose (crystals). Preferably, the nanocellulose is extracted from wood pulp cellulose. Pre-treatments can be used, such as TEMPO-mediated oxidation. Thus, the sheet can also be formed by using TEMPO-oxidized nanocellulose. Of course, any combination or source can be used for the nanocellulose in order to create sheet 10. Once sheet 10 is formed, the details of which are discussed and illustrated at length in the subsequent text, sheet 10 is cut into different shapes. The following discussion describes and illustrates many of the possible applications of the sheet 10. The following discussion should not, however, limit the scope of the applications of the invention.

(11) Generally, the method is capable of forming a hydrated nanocellulose sheet 10 (illustrated in FIG. 1). Once a nanocellulose sheet 10 is formed, it can be cut into a form which is capable of applying to the skin of a user. The form can be any different shape, size or configuration. The different shapes and sizes formed can be used for different applications. These applications are mainly based in dermatology, including wound healing, cosmetology, and other applications involving the skin. The following illustrations, FIGS. 2A-2D, are illustrations of different applications for nanocellulose sheet 10.

(12) FIG. 2A shows a mask 12 which has been cut from a nanocellulose sheet 10. This mask 12 can be applied to a user's entire face. Due to the method of manufacture of sheet 10 (and therefore mask 12) has advantageous properties, further discussed herein, that prior art masks or other applications of sheet were not capable of achieving.

(13) FIG. 2B shows another embodiment of the present invention. In this embodiment of the present invention, sheet 10 has been cut into a form of under eye masks 13. As shown, each under eye mask 13 is cut in a shape that fits under the eye of a patient. FIG. 2C shows an embodiment of the present invention which has multiple applications. Side of face masks 15 can be applied to either side of a user's mouth or on either side of a user's eyes. These are locations on a user's face which are typically targeted with dermatological ingredients. FIG. 2D shows another embodiment of the present invention. Neck wrap 17 is a form that can be wrapped around the neck of a user in order to apply dermatological ingredients to a user's neck.

(14) In each embodiment of the present invention, the nanocellulose nonwoven sheet achieves a similar end—formation of a hydrated, nanocellulose nonwoven sheet which incorporates dermatological active ingredients in order to enhance the effects of applying a dermatological sheet mask 12.

(15) Generally, the method comprises producing a nanocellulose sheet 10 by a series of steps. The desired nanocellulose sheet 10 is achieved independent of the specific order of the steps after step 1 and 2. As shown in FIG. 3, step 1 comprises providing purified nanocellulose. The present method can utilize nanocellulose having any diameter and length. For example, the nanocellulose may have a diameter of 5 to 100 nm and length of up to 10 microns. In step 2, the nanocellulose is diluted into a suspension to a mass concentration of 0.1 gram per liter to 10 grams per liter. The nanocellulose can be diluted with any suspension medium capable of being combined with the cellulose to form a stable suspension. For example, water, alcohols or oil (having a surfactant) can be used as the suspension medium.

(16) Generally, the remaining steps of the method comprise the steps of, at least: Placing suspension into a dispensing device for micro-filtration; Preparation of a cross-linking solution such as calcium lactate, calcium chloride, calcium stearate or oil, which is capable of cross-linking or “setting” the binding agent, where relevant; Application of cross-linking solution; and collection of the formed sheet.

(17) The dispensing device can be any device that is capable of micro-filtration and/or fabricating sheets of nanomaterials. The device disclosed in U.S. application Ser. No. 14/186,795 is one example of a device that can be used in the present method. During the filtration process, the device or filter removes water from the suspension leaving a solid sheet. The solid sheet is, in one example, 20-80% solids.

(18) The claimed method of manufacturing comprising the formation of hydrated nanocellulose sheets with or without a binder for the use as a dermatological treatment also includes several optional steps capable of being utilized in various method embodiments.

(19) For example, optional steps include the addition of particulate dermatologically active ingredients or desired base material modifiers, collectively “ingredients” (some examples of base material modifiers are other forms of cellulose fibers, other forms of nanofibers, nanoclay, extended release particles, and micro-encapsulates), addition of wet binding agent/gelling agent, such as sodium alginate or agar, to a mass concentration of 0.01 grams per liter to 10 grams per liter, dewatering of sheet to a 10-70% water content, collection and re-dispersion of gel in solution by mixing or blending, filtration of suspension with positive pressure or vacuum to the filter paper, addition of liquid active agents to formed sheet and/or packaging of material in gas impermeable package.

(20) Generally, the method is capable of forming a hydrated nanocellulose sheet 10 (illustrated in FIG. 1). As discussed above, once a nanocellulose sheet 10 is formed it can be cut into different shapes, sizes, and configurations (illustrated in FIG. 2A-2D). Due to the method of manufacture of nanocellulose sheet 10, it has advantageous properties that prior art sheets were not capable of achieving. For example, nanocellulose sheet 10 has a high conformability and drape-ability, a high surface area, a good level of adhesion to the skin, the ability to trap nano and micro particles, and a high rate of evaporation of water from the sheet. Conformability, drape-ability, high surface area and adhesion to the skin are characteristics that make the material ideal for lying against the skin and delivery dermatological agents. The ability to contain nano and micro particles, as well as absorbing aqueous solutions make the material ideal as a delivery mechanism for dermatological agents that have been difficult to deliver or require multi-step processes to deliver to the skin. Thus, nanocellulose sheet 10 (in any form, examples include FIGS. 2A-2D) is capable of delivering dermatological agents or other ingredients more effectively and for a longer period of time than prior art sheets, including, but not limited to facial masks, eye masks, neck wrap, etc.

(21) Nanocellulose is defined as cellulose particles or fibers that have at least one dimension that is measured in nanometers which have been exfoliated from cellulose fibrils via mechanical or chemical processes. Nanocellulose can be produced from many sources including bacterial, plant, wood, algal or fruit waste. In the present method, it is important that the steps include the dilution of nanocellulose into a suspension, instead of processing a grown pellicle of nanocellulose (such as is common in bacterially grown cellulose). The delivery of the nanocellulose in a suspension allows the process to accept nanocellulose from multiple sources. Nanocellulose can be pre-treated during formation. Examples of such pre-treatment include mechanical or enzymatic treatment of a cellulose containing material. Cellulose containing material can be oxidized using 2,2,6,6-tetramethylpiperidin-1-oxyl radical (“TEMPO”), which introduces charged groups. Carboxymethoylation can also be used to pre-treat the cellulose containing material. Finally, acid hydrolysis, such as acid hydrolysis can be used to treat the cellulose containing material.

(22) The present method, although not required, allows ingredients to be added at different stages of formation of the sheet. The addition of the ingredients at different stages allows interaction and binding of ingredients prior to full formation of the sheet. The ingredients bind closely to the nanocellulose. The ingredients are therefore imbedded or absorbed at this stage. This method is capable of achieving even dispersion of ingredients through the thickness of the material. A greater concentration of ingredients is attained than would be by simply allowing a formed sheet to absorb the ingredients. Ingredients can be any ingredients which are added to the sheet 10 during the manufacture for delivery to the skin of the user or to modify the properties of the sheet itself (e.g. increase its permeability). These ingredients can be for use in many industries, such as cosmetic or pharmaceutical. While any known ingredients can be used, some examples include silver, collagen, proteins, fragrances or antioxidants (e.g. blended green tea).

(23) In one embodiment of the present method, illustrated in FIG. 3, sheet 10 is manufactured by a method (method A), without adding a binder or active ingredients before the sheet is formed. Such method generally comprising the steps of:

(24) (1) Providing purified nanocellulose material or its combination.

(25) (2) Dilution of nanocellulose 16 into a first suspension to a mass concentration of 0.1 gram per liter to 10 grams per liter. The nanocellulose can be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. For example, H.sub.2O, alcohol or oil (having a surfactant) can be used as the suspension medium.

(26) (3) Placement of suspension into a dispensing device 18.

(27) (4) Filtration of suspension with positive pressure or vacuum to the filter paper 28 such that a sheet is formed.

(28) (5) Dipping formed sheet into a binding and/or cross linking agent. The manufacturer can dip sheet into a binding agent solution wherein the binding agent solution is a binding agent diluted to a mass concentration of 0.01 grams per liter to 10 grams per liter and/or dip sheet into a cross linking solution wherein said cross linking solution is a cross linking agent diluted to a mass concentration of 0.001 grams per liter to 20 grams per liter.

(29) (6) Dipping formed sheet into an ingredient slurry 32.

(30) (7) Cutting sheet into a form 34, such as a facial mask, neck wrap, under eye masks, to name a few.

(31) (8) Packaging of sheet, such as in gas impermeable package 36.

(32) In this embodiment, the method is capable of forming a nanocellulose sheet 10 which allows for the incorporation of particulate and solution-based active ingredients in the formation of the material. However, the aqueous solution of nanoparticles does not require use of binders, fillers or adhesives.

(33) Another embodiment of the present invention, method B, is illustrated in FIG. 4 and generally comprises the following steps:

(34) (1) Providing purified nanocellulose material or its combination,

(35) (2) Dilution of nanocellulose 16 into a first suspension to a mass concentration of 0.1 gram per liter to 10 grams per liter. The nanocellulose can be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. For example, H.sub.2O, alcohol or oil (having a surfactant) can be used as the suspension medium.

(36) (3) Addition of binding agent to first suspension 38 to a mass concentration of 0.01 grams per liter to 10 grams per liter to form a binding agent solution.

(37) (4) Diluting cross-linking agent 20 in a solvent (such as water) to a mass concentration of 0.001 grams per liter to 20 grams per liter to form a cross-linking solution, wherein said cross-linking agent can be calcium lactate, calcium chloride, calcium stearate or oil.

(38) (5) Dispensing first suspension into cross-linking solution 22.

(39) (6) Collection of formed gel from cross-linking solution 24.

(40) (7) Re-dispersing the formed gel in a solution to form a second suspension 26.

(41) (8) Filtration of the second suspension with positive pressure or vacuum to the filter paper 28.

(42) (9) Collection of formed sheet 30.

(43) (10) Dipping formed sheet into an ingredient slurry 32.

(44) (11) Cutting sheet into a form 34, such as a facial mask, neck wrap, under eye masks, to name a few.

(45) (12) Packaging of sheet in gas impermeable package 50.

(46) In another embodiment of the present invention, method C, illustrated in FIG. 5, the steps for manufacturing the unwoven sheet are:

(47) (1) Providing purified nanocellulose material or its combination 14.

(48) (2) Dilution of nanocellulose 16 into a first suspension to a mass concentration of 0.1 gram per liter to 10 grams per liter. The nanocellulose can be diluted with any suspension medium capable of being combined with the nanocellulose to form a stable suspension. For example, H.sub.2O, alcohol or oil (having a surfactant) can be used as the suspension medium.

(49) (3) Addition of particulate 20 dermatologically active ingredients or desired base material modifiers. Some examples of base material modifiers are nanoclay, extended release particles, and microencapsulates.

(50) (4) Addition of wet binding agent/gelling agent 38, such as sodium alginate or agar, to first suspension to a mass concentration of 0.01 grams per liter to 10 grams per liter. Although sodium alginate and agar are used as examples, the binding agent/gelling agent can be any polycationic, such as polyamidoamine-epichlorohydrin or KYMENE, and/or anionic such as carboxymethylcellulose or Hyaluronic acid.

(51) (5) Diluting cross-linking agent 20, such as calcium citrate, calcium lactate, calcium chloride, calcium stearate or oil, appropriate to selected wet binding agent in a solvent (such as water) to a mass concentration of 0.001 grams per liter to 20 grams per liter to form a cross-linking solution.

(52) (6) Dispensing first suspension into cross-linking solution 22.

(53) (7) Collection of formed gel from cross-linking solution 24.

(54) (8) Re-dispersion of gel in solution by mixing or blending 26 to form a second suspension.

(55) (9) Filtration of suspension 28 with positive or vacuum pressure until sheet is formed.

(56) (10) Collection of formed sheet 30.

(57) (11) Optionally adding liquid or solid active agents or ingredients by dipping formed sheet into an ingredient slurry 32.

(58) (12) Packaging of sheet in, for example, a gas-impermeable package 50.

(59) Method C allows for the incorporation of particulate dermatologically active ingredients 20 before and after the addition of the wet binding agent 38. Thus, the active ingredients can be uniformly dispersed throughout the thickness of the sheet 10, allowing sheet 10 to accept active ingredients in greater proportions.

(60) The preceding description contains significant detail regarding the novel aspects of the present method. It should not be construed, however, as limiting the scope of the invention but rather as providing illustrations of the preferred embodiments of the invention.